Gene · 406902
Papers3,238
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,238
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Regulatory Role of MicroRNAs on Phagocytes: A Potential Therapeutic Target for Chronic Diseases. | Front Immunol | 2022 | 35634335 | PubTator, text mining | PubMed |
| Characterization of Viral miRNAs during Adenovirus 14 Infection and Their Differential Expression in the Emergent Strain Adenovirus 14p1. | Viruses | 2022 | 35632641 | PubTator, text mining | PubMed |
| Lymphatic and Blood Endothelial Extracellular Vesicles: A Story Yet to Be Written. | Life (Basel) | 2022 | 35629322 | PubTator, text mining | PubMed |
| Implication of microRNAs in Carcinogenesis with Emphasis on Hematological Malignancies and Clinical Translation. | Int J Mol Sci | 2022 | 35628648 | PubTator, text mining | PubMed |
| Profiling of Non-Coding Regulators and Their Targets in Epicardial Fat from Patients with Coronary Artery Disease. | Int J Mol Sci | 2022 | 35628106 | PubTator, text mining | PubMed |
| Analysis of miR-143, miR-1, miR-210 and let-7e Expression in Colorectal Cancer in Relation to Histopathological Features. | Genes (Basel) | 2022 | 35627259 | PubTator, text mining | PubMed |
| Breast Cancer-Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature). | Cancers (Basel) | 2022 | 35626173 | PubTator, text mining | PubMed |
| TGF-β as a Key Modulator of Astrocyte Reactivity: Disease Relevance and Therapeutic Implications. | Biomedicines | 2022 | 35625943 | PubTator, text mining | PubMed |
| Melatonin Modulation of Radiation-Induced Molecular Changes in MCF-7 Human Breast Cancer Cells. | Biomedicines | 2022 | 35625825 | PubTator, text mining | PubMed |
| The Roles and Regulation of m6A Modification in Glioblastoma Stem Cells and Tumorigenesis. | Biomedicines | 2022 | 35625706 | PubTator, text mining | PubMed |
| Hepatocellular Carcinoma: The Role of MicroRNAs. | Biomolecules | 2022 | 35625573 | PubTator, text mining | PubMed |
| SMMDA: Predicting miRNA-Disease Associations by Incorporating Multiple Similarity Profiles and a Novel Disease Representation. | Biology (Basel) | 2022 | 35625505 | PubTator, text mining | PubMed |
| The Involvement of Long Non-Coding RNAs in Glioma: From Early Detection to Immunotherapy. | Front Immunol | 2022 | 35619711 | PubTator, text mining | PubMed |
| The Role, Significance, and Association of MicroRNA-10a/b in Physiology of Cancer. | Microrna | 2022 | 35616665 | PubTator, text mining | PubMed |
| Long non-coding RNA MIR22HG suppresses cell proliferation and promotes apoptosis in prostate cancer cells by sponging microRNA-9-3p. | Bioengineered | 2022 | 35611601 | PubTator, text mining | PubMed |
| Factor VIIa treatment increases circulating extracellular vesicles in hemophilia patients: Implications for the therapeutic hemostatic effect of FVIIa. | J Thromb Haemost | 2022 | 35608928 | PubTator, text mining | PubMed |
| Extracellular vesicle biomarkers for pancreatic cancer diagnosis: a systematic review and meta-analysis. | BMC Cancer | 2022 | 35606727 | PubTator, text mining | PubMed |
| Time-course full profiling of circulating miRNAs in neurologically deceased organ donors: a proof of concept study to understand the onset of the cytokine storm. | Epigenetics | 2022 | 35603508 | PubTator, text mining | PubMed |
The functional activity of donor kidneys is negatively regulated by microribonucleic acid-451 in different perfusion methods to inhibit adenosine triphosphate metabolism and the proliferation of HK2 cells. | Bioengineered | 2022 | 35603466 | PubTator, text mining | PubMed |
| Inflammation-Related Epigenetic Modification: The Bridge Between Immune and Metabolism in Type 2 Diabetes. | Front Immunol | 2022 | 35603204 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406902/papers?page=35